Our biomarker for out-licensing
DPP3 biomarker guides doctors to act on the right information at the right time in intensive care units. |
It is available for out-licensing to global In-Vitro Diagnostics and pharmaceutical companies. |
6 Patent families covering the use of DPP3 biomarker for various medical purposes
Supported by
The project is funded by the European Social Fund (ESF) and the Federal State of Brandenburg via the Brandeburg Ministry for Labor, Social Affairs, Health, Women and Family (MASGF).